• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体介导的血脑屏障穿透磁性纳米颗粒递药。

Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier.

机构信息

Institute of Chemistry, Chinese Academy of Sciences, Bei Yi Jie 2, Zhong Guan Cun, Beijing 100190, China.

出版信息

ACS Nano. 2012 Apr 24;6(4):3304-10. doi: 10.1021/nn300240p. Epub 2012 Mar 29.

DOI:10.1021/nn300240p
PMID:22443607
Abstract

A brain delivery probe was prepared by covalently conjugating lactoferrin (Lf) to a poly(ethylene glycol) (PEG)-coated Fe(3)O(4) nanoparticle in order to facilitate the transport of the nanoparticles across the blood-brain barrier (BBB) by receptor-mediated transcytosis via the Lf receptor present on cerebral endothelial cells. The efficacy of the Fe(3)O(4)-Lf conjugate to cross the BBB was evaluated in vitro using a cell culture model for the blood-brain barrier as well as in vivo in SD rats. For an in vitro experiment, a well-established porcine BBB model was used based on the primary culture of cerebral capillary endothelial cells grown on filter supports, thus allowing one to follow the transfer of nanoparticles from the apical (blood) to the basolateral (brain) side. For in vivo experiments, SD rats were used as animal model to detect the passage of the nanoparticles through the BBB by MRI techniques. The results of both in vitro and in vivo experiments revealed that the Fe(3)O(4)-Lf probe exhibited an enhanced ability to cross the BBB in comparison to the PEG-coated Fe(3)O(4) nanoparticles and further suggested that the Lf-receptor-mediated transcytosis was an effective measure for delivering the nanoparticles across the BBB.

摘要

为了通过脑内皮细胞上的乳铁蛋白受体介导的胞吞作用促进纳米颗粒穿过血脑屏障(BBB),将乳铁蛋白(Lf)共价偶联到聚乙二醇(PEG)包覆的 Fe(3)O(4)纳米颗粒上,制备了脑内递药探针。使用基于在过滤器支持物上生长的脑毛细血管内皮细胞的原代培养的成熟猪 BBB 模型,在体外评估了 Fe(3)O(4)-Lf 缀合物穿过 BBB 的功效,以及在 SD 大鼠体内的功效。对于体内实验,使用 SD 大鼠作为动物模型,通过 MRI 技术检测纳米颗粒穿过 BBB 的情况。体外和体内实验的结果均表明,与 PEG 包覆的 Fe(3)O(4)纳米颗粒相比,Fe(3)O(4)-Lf 探针具有增强的穿过 BBB 的能力,并且进一步表明乳铁蛋白受体介导的胞吞作用是将纳米颗粒穿过 BBB 的有效手段。

相似文献

1
Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier.受体介导的血脑屏障穿透磁性纳米颗粒递药。
ACS Nano. 2012 Apr 24;6(4):3304-10. doi: 10.1021/nn300240p. Epub 2012 Mar 29.
2
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.具有转胞吞作用且对血脑屏障毒性小的阳离子白蛋白共轭聚乙二醇化纳米颗粒。
Int J Pharm. 2005 May 13;295(1-2):247-60. doi: 10.1016/j.ijpharm.2005.01.043.
3
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.乳铁蛋白修饰的前离子脂质体作为一种新型脑递药载体。
Eur J Pharm Sci. 2010 May 12;40(2):94-102. doi: 10.1016/j.ejps.2010.03.007. Epub 2010 Mar 16.
4
Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.利用血管肽(Angiopep)缀合的聚乙二醇修饰的聚酰胺-胺树枝状聚合物进行脑内靶向基因传递。
Biomaterials. 2009 Dec;30(36):6976-85. doi: 10.1016/j.biomaterials.2009.08.049. Epub 2009 Sep 17.
5
Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.建立用于纳米颗粒转胞吞作用及毒性评估的体外血脑屏障共培养模型。
Yao Xue Xue Bao. 2006 Apr;41(4):296-304.
6
Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.乳铁蛋白修饰的聚乙二醇接枝牛血清白蛋白纳米粒作为治疗脑胶质瘤的双靶向载体
Mol Pharm. 2014 Jun 2;11(6):1823-34. doi: 10.1021/mp500238m. Epub 2014 May 15.
7
A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.一种新型乳铁蛋白修饰的β-环糊精纳米载体用于脑靶向药物递送。
Int J Pharm. 2013 Dec 15;458(1):110-7. doi: 10.1016/j.ijpharm.2013.10.005. Epub 2013 Oct 12.
8
Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.阳离子白蛋白偶联聚乙二醇化纳米颗粒的脑递送特性及加速血液清除
J Control Release. 2007 Mar 12;118(1):38-53. doi: 10.1016/j.jconrel.2006.11.015. Epub 2006 Nov 24.
9
Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.由胆固醇封端的聚乙二醇-穿膜肽自组装而成的具有生物活性的核壳纳米颗粒用于药物跨血脑屏障递送。
Biomaterials. 2008 Apr;29(10):1509-17. doi: 10.1016/j.biomaterials.2007.11.014. Epub 2007 Dec 21.
10
Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.通过延长的聚乙二醇连接子与血脑屏障给药载体偶联后人表皮生长因子生物活性的保留
Bioconjug Chem. 1999 Jan-Feb;10(1):32-7. doi: 10.1021/bc9800522.

引用本文的文献

1
Advancing glioblastoma therapy with surface-modified nanoparticles.利用表面改性纳米颗粒推进胶质母细胞瘤治疗
Neurol Sci. 2025 Sep 13. doi: 10.1007/s10072-025-08457-4.
2
Mechanical stimulation prevents impairment of axon growth and overcompensates microtubule destabilization in cellular models of Alzheimer's disease and related Tau pathologies.在阿尔茨海默病及相关 Tau 病变的细胞模型中,机械刺激可防止轴突生长受损,并过度补偿微管的去稳定化。
Front Med (Lausanne). 2025 May 14;12:1519628. doi: 10.3389/fmed.2025.1519628. eCollection 2025.
3
In vitro and in vivo assessment of diosmetin-loaded lactoferrin-modified liposomes for brain delivery in intracerebral hemorrhage therapy.
用于脑出血治疗中脑递送的载有香叶木素的乳铁蛋白修饰脂质体的体外和体内评估
Drug Deliv Transl Res. 2025 Mar 15. doi: 10.1007/s13346-025-01826-8.
4
Interfacing with the Brain: How Nanotechnology Can Contribute.与大脑交互:纳米技术如何发挥作用。
ACS Nano. 2025 Mar 25;19(11):10630-10717. doi: 10.1021/acsnano.4c10525. Epub 2025 Mar 10.
5
γ-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma.γ-谷氨酰转肽酶激活型纳米探针经血脑屏障用于脑胶质瘤免疫声动力学治疗。
Nat Commun. 2024 Nov 29;15(1):10418. doi: 10.1038/s41467-024-54382-z.
6
Nanotechnology approaches to drug delivery for the treatment of ischemic stroke.用于治疗缺血性中风的纳米技术药物递送方法。
Bioact Mater. 2024 Sep 23;43:145-161. doi: 10.1016/j.bioactmat.2024.09.016. eCollection 2025 Jan.
7
Nanoparticles in CNS Therapeutics: Pioneering Drug Delivery Advancements.中枢神经系统治疗中的纳米颗粒:开创性的药物递送进展。
Curr Pharm Des. 2025;31(6):443-460. doi: 10.2174/0113816128328722240828184410.
8
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood-Brain Barrier.无受体配体的介孔硅纳米粒子:一种跨越血脑屏障的靶向药物递送的简化策略。
ACS Nano. 2024 May 21;18(20):12716-12736. doi: 10.1021/acsnano.3c08993. Epub 2024 May 8.
9
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review.纳米材料作为克服血脑屏障的药物递送剂:综述
ADMET DMPK. 2023 Oct 31;12(1):63-105. doi: 10.5599/admet.2043. eCollection 2024.
10
Receptor-Assisted Nanotherapeutics for Overcoming the Blood-Brain Barrier.受体介导的纳米治疗克服血脑屏障。
Mol Neurobiol. 2024 Nov;61(11):8702-8738. doi: 10.1007/s12035-024-04015-9. Epub 2024 Apr 1.